Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
The ELISA is an immunological assay generally used for the measurement of antibodies, antigens, proteins and glycoproteins which are likely to present in the biological samples. Some of examples includes the diagnosis of HIV infection, pregnancy test and measurement of cytokines or soluble receptors in the supernatant or serum. ELISA assay are commonly carried out in 96 well plates, allowing multiple samples to be measured in a single experiment. These plates need to be special absorbant plates such as immuno plates to ensure the antibody or antigen stick to the surface. Every ELISA measures a specific antigen and kits for a variety of antigens are widely available.
The North America Enzyme-linked immunosorbent assay market is witnessing lucrative growth during the forecast period of 2019 - 2028. The ELISA works on the principle that specific antibodies bind the target and detect the presence and quality of antigen binding. In order to rise the sensitivity along with precision of the assay, the plate must be coated with antibodies whose having high affinity. The key factor such as increasing prevalence of chronic and infectious diseases is propelling growth of market. The rising awareness regarding early diagnosis is also boosting growth of market. However, technical hurdle in kits is hindering the growth of market.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the Enzyme-linked immunosorbent assay market. In addition, complete analysis of changes on Enzyme-linked immunosorbent assay expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on North America economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 has almost affected every market is healthcare industries positively or negatively. The rising cases of COVID-19 and adoption of technically advanced test for detection of infectious diseases in patients is rising demand of Enzyme-linked immunosorbent assay. The Enzyme-linked immunosorbent assay test is more sensitive than other tests for detection of infectious disease in patients. Thereby, the Enzyme-linked immunosorbent assay market has positive impact of COVID-19.
The North America Enzyme-linked immunosorbent assay market is bifurcated into the type, application, end user and country.
Type of ELISA test such as sandwich ELISA, indirect ELISA, direct ELISA and competitive ELISA are comprised in the North America enzyme-linked immunosorbent assay market. In which direct ELISA is also contributing to the growth of market in 2020. The direct ELISA is a plate-based immunosorbent assay intended for the detection and quantification of a specific analytes such as antigen, antibodies, proteins, hormones and peptides in the complex biological samples.
Application such as vaccine development, immunology, diagnostic, toxicology, drug monitoring and pharmaceutical and transplantation. In which vaccine development is also contributing to the growth of market in 2020. The enzyme-linked immunosorbent assay has been widely used for the measurement of antibody titers for the evaluating the immunogenicity of the vaccine. The rising focus on development of vaccines for the various viral diseases is propelling growth of North America enzyme-linked immunosorbent assay market.
End users such as hospital and diagnostic centres, research laboratories and other are comprised in the North America enzyme-linked immunosorbent assay market. In which research laboratories are also contributing to the growth of North America enzyme-linked immunosorbent assay market. The growing research and development activities is propelling growth of North America enzyme-linked immunosorbent assay market. The growing demand for early diagnosis is also boosting growth of North America enzyme-linked immunosorbent assay market.
The North America enzyme-linked immunosorbent assay market is studied for key countries such as US, Mexico and Canada. In which US is anticipated to dominate the market in 2020. The growing disposable income is boosting growth of North America enzyme-linked immunosorbent assay market. The rising research and development activities is also refuelling growth of North America enzyme-linked immunosorbent assay market. The rising prevalence of infectious diseases is also propelling growth of North America enzyme-linked immunosorbent assay market.
The major key players of Enzyme-linked immunosorbent assay market are Alpco, Abcam Plc, Agilent Technologies Inc., BD Biosciences, Bio-Rad Laboratories Inc., Biolegend Inc., Enzo Life Sciences Inc., F. Hoffmann-La Roche Ltd., Merck Kgaa, Mercodia Ab, Ortho-Clinical Diagnostics Inc., Perkinelmer Inc., Qiagen Nv, R&D Systems Inc., Shenzen Yhlo Biotech Co. Ltd., Thermo Fischer Scientific Inc., Zeus Scientific, Inc. and Biomérieux Sa among others.
February 2021: The Thermo Fisher Scientific Inc., acquired the private point of care molecular diagnostic company named as Mesa Biotech.
February 2020: The Becton Dickinson and Co. reported a collaborated with Babson Diagnostic for bringing lab quality, little volume blood assortment to retail drug stores.
March 2018: BARD1 Life sciences, The U.S. based science research company is expected the commercialization of BARD1-Ovarian blood based ELSIA test for distinguishing ovarian diseases in the beginning phase.
January 2018: The Eagle Biosciences Inc., presented a novel unblemished FGF23 ELISA unit test which is the 96 well sandwich ELISA examination. It is estimated as full-length dynamic type of human Intact FGF23 utilized for the discovery of mineral bone disorder, chronic kidney disorder, chronic kidney disease and hyperphosphatemia.
The report analyses the Enzyme-linked immunosorbent assay market based on type, application, end user and country. The various type of ELISA test covered in the report are sandwich ELISA, indirect ELISA, direct ELISA and competitive ELISA. By application, the market is segmented into the vaccine development, immunology, diagnostics, toxicology, drug monitoring and pharmaceuticals and transplantation. Based on end user, the market is segmented into the hospital and diagnostic centre, research laboratories and other. The report also analyses the impact of COVID-19 on the Enzyme-linked immunosorbent assay market and it is analyses that the COVID-19 has almost affected every market is healthcare industries positively or negatively. The rising cases of COVID-19 and adoption of technically advanced test for detection of infectious diseases in patients is rising demand of Enzyme-linked immunosorbent assay. The Enzyme-linked immunosorbent assay test is more sensitive than other tests for detection of infectious disease in patients. Thereby, the Enzyme-linked immunosorbent assay market has positive impact of COVID-19. The report also covers the major key players operating in the market.
Why to buy this report
